reports
Acuity Reports Fiscal 2025 Fourth-Quarter and Full-Year Results
Acuity Reports Fiscal 2025 Fourth-Quarter and Full-Year Results Strong Execution in the Fourth-Quarter Delivered Net Sales Growth and Improved Operating Performance Increased Fiscal Q4 2025 Net Sales 17% to $1.2B Compared to the Prior Year Reported Fiscal Q4 2025 Diluted EPS of $3.61, down 4% Over the Prior Year; Adjusted Diluted EPS of $5.20, up 21% Over the Prior Year Delivered Fiscal 2025 Net Sales of $4.3B, a 13% Increase Compared to the Prior Year Reported Fiscal 2025 Diluted EPS of $12.53, down 7% Over the Prior Year; Adjusted Diluted EPS of $18.01, up 16% Over the Prior Year Generat...
Acuity Inc. Declares Quarterly Dividend
Acuity Inc. Declares Quarterly Dividend Atlanta, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE: AYI) will pay a quarterly dividend of 17 cents per share. The dividend is payable on November 3, 2025, to shareholders of record on October 17, 2025. About Acuity Acuity Inc. (NYSE: AYI) is a market-leading industrial technology company. We use technology to solve problems in spaces, light and more things to come. Through our two business segments, Acuity Brands Lighting (ABL) and Acuity Intelligent Spaces (AIS), we design, manufacture, and bring to market products and services that...
- Jonathan Moreland
TPVG TRIPLEPOINT VENTURE GROWTH BDC CORP
TNDM TANDEM DIABETES CARE INC
RYAM RAYONIER ADVANCED MATERIALS INC
OPK OPKO HEALTH INC.
NEO NEOGENOMICS INC.
MTDR MATADOR RESOURCES COMPANY
KURA KURA ONCOLOGY INC.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
ICUI ICU MEDICAL INC.
EMN EASTMAN CHEMICAL COMPANY
EIG EMPLOYERS HOLDINGS INC.
D DOMINION ENERGY INC
COTY COTY INC. CLASS A
CNC CENTENE CORPORATION
CHD CHURCH & DWIGHT CO. INC.
ARW ARROW ELECTRONICS INC.
ALGN ALIGN TECHNOLOGY INC.
UPS UNITED PARCEL SERVICE INC. CLASS B
AROW ARROW FINANCIAL CORP.
KODK EASTMAN KODAK CO
AAOI APPLIED OPTOELECTRONICS INC.
ADC AGREE REALTY CORPORATION
HTLD HEARTLAND EXPRESS INC.
BSM BLACK STONE MINERALS LP
VVV VALVOLINE INC.
GBLI GLOBAL INDEMNITY PLC
FTV FORTIVE CORP.
SMRT SMARTSPACE SOFTWARE
CCEL CRYO-CELL INTERNATIONAL
SONO SONOS
ESTA ESTABLISHMENT LABS HOLDINGS
WU THE WESTERN UNION COMPANY
TROX TRONOX HOLDINGS PLC
LUMN LUMEN TECHNOLOGIES INC.
VTRS VIATRIS INC
ENVX ENOVIX CORP
PTLO PORTILLOS INC
EBC EASTERN BANKSHARES INC
MSDL MORGAN STANLEY DIRECT LENDING
BKKT BAKKT HOLDINGS INC.
FIP FTAI INFRASTRUCTURE INC
MRAI MARPAI
MDRR INC.
BOOM MEDALIST DIVERSIFIED REIT INC.
EFOI DYNAMIC MATERIALS CORPORATION
STSS ENERGY FOCUS INC.
SHARPS TECHNOLOGY INC.
Acuity to Announce Fiscal 2025 Fourth-Quarter and Full-Year Results on...
Acuity to Announce Fiscal 2025 Fourth-Quarter and Full-Year Results on October 1, 2025 ATLANTA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE: AYI) (the “Company”) will release fiscal 2025 fourth-quarter and full-year results on Wednesday, October 1, 2025 at 6:00 a.m. ET, followed by a conference call at 8:00 a.m. ET. Neil Ashe, Chief Executive Officer of Acuity Inc., will lead the call. The webcast, earnings release, and supplemental presentation can be accessed via the Investor Relations section of the Company's at on Wednesday, October 1, 2025. The online replay will remain av...
- Dave Nicoski
- Ross LaDuke
- Jonathan Moreland
VRTX VERTEX PHARMACEUTICALS INCORPORATED
TFX TELEFLEX INCORPORATED
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
SHBI SHORE BANCSHARES INC.
PNFP PINNACLE FINANCIAL PARTNERS INC.
OPK OPKO HEALTH INC.
NSP INSPERITY INC.
NPO ENPRO INDUSTRIES INC.
MTDR MATADOR RESOURCES COMPANY
MMLP MARTIN MIDSTREAM PARTNERS L.P.
LLY ELI LILLY AND COMPANY
KMPR KEMPER CORPORATION
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
EIG EMPLOYERS HOLDINGS INC.
CNOB CONNECTONE BANCORP INC.
CHTR CHARTER COMMUNICATIONS INC. CLASS A
CHD CHURCH & DWIGHT CO. INC.
CDXS CODEXIS
ARW ARROW ELECTRONICS INC.
AMH AMERICAN HOMES 4 RENT CLASS A
CIVB CIVISTA BANCSHARES
OLN OLIN CORPORATION
ASUR ASURE SOFTWARE INC
BRO BROWN & BROWN INC.
CYRX CRYOPORT INC.
FTV FORTIVE CORP.
CLAR CLARUS CORPORATION
A2H9KJ NEO PERFORMANCE MATERIAL
OSPN ONESPAN
FXNC FIRST NATIONAL CORP. OF VIRGINIA
TROX TRONOX HOLDINGS PLC
MEC MAYVILLE ENGINEERING
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
XRX XEROX HOLDINGS CORPORATION
PINE ALPINE INCOME PROPERTY TRUST
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
LRMR LARIMAR THERAPEUTICS INC
THRY THRYV HOLDINGS
DLHC DALEIGH HOLDINGS CORP
INTA INTAPP INC
PTLO PORTILLOS INC
BRBR BELLRING BRANDS INC
AUB ATLANTIC UNION BANKSHARES CORP
AURX NUO THERAPEUTICS
OI INC.
SIRI OWENS ILLINOIS INC.
XELB SIRIUS XM HLDGS INC NEW
MUSA XCEL BRANDS INC.
LNW METALS USA HOLDINGS CORP.
LIGHT & WONDER INC.
- Jonathan Moreland
PNFP PINNACLE FINANCIAL PARTNERS INC.
OPK OPKO HEALTH INC.
NPO ENPRO INDUSTRIES INC.
LLY ELI LILLY AND COMPANY
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
BRO BROWN & BROWN INC.
CRSP CRISPR THERAPEUTICS AG
OSPN ONESPAN
TROX TRONOX HOLDINGS PLC
MEC MAYVILLE ENGINEERING
PINE ALPINE INCOME PROPERTY TRUST
PTLO PORTILLOS INC
AUB ATLANTIC UNION BANKSHARES CORP
LNW LIGHT & WONDER INC.
Opko Health Inc: 1 director
A director at Opko Health Inc bought 675,000 shares at 1.320USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
- Jonathan Moreland
VRTX VERTEX PHARMACEUTICALS INCORPORATED
TFX TELEFLEX INCORPORATED
KMPR KEMPER CORPORATION
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
AMH AMERICAN HOMES 4 RENT CLASS A
OLN OLIN CORPORATION
CZWI CITIZENS COMMUNITY BANCORP
CLAR CLARUS CORPORATION
LOOP LOOP INDUSTRIES
FXNC FIRST NATIONAL CORP. OF VIRGINIA
TROX TRONOX HOLDINGS PLC
AUB ATLANTIC UNION BANKSHARES CORP
OI OWENS ILLINOIS INC.
OPKO Health Reports Second Quarter 2025 Business Highlights and Financ...
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2025. Highlights from the second quarter of 2025 and recent weeks include the following: Merck advanced Phase 1 Epstein-Barr virus vaccine trial (). This investigational vaccine candidate is being developed in collaboration with Merck and evaluates safety and tolerability in up to 200 h...
OPKO Health to Report Second Quarter 2025 Financial Results on July 31
OPKO Health to Report Second Quarter 2025 Financial Results on July 31 MIAMI, July 24, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Thursday, July 31, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on July 31 beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-re...
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Ta...
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress MIAMI and JERUSALEM, July 08, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (“OPKO”) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that their abstract “First-in-Class Oral GLP-2 Analog for Treatment of Short Bowel Syndrome” has been selected for a poster presentation at the 47th European Society for Clinical Nutrition & Metabolism (“ESPEN”) Congress, taking place September 13–16, 2025, in Prague, Czech Republic. A...
Acuity Inc: 1 director
A director at Acuity Inc sold/sold after exercising options 4,125 shares at 298.304USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...
Acuity Reports Fiscal 2025 Third-Quarter Results
Acuity Reports Fiscal 2025 Third-Quarter Results Strong Performance Delivers Sales Growth in Both Lighting and Intelligent Spaces Delivered Net Sales of $1.2B, an Increase of 22% Compared to the Prior YearDelivered Operating Profit of $140M, Down 4 % Compared to the Prior Year; Grew Adjusted Operating Profit to $222M, Up 33% Compared to the Prior YearDelivered Diluted EPS of $3.12, Down 14% Compared to the Prior Year; Grew Adjusted Diluted EPS to $5.12, Up 23% Compared to the Prior Year ATLANTA, June 26, 2025 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE: AYI), ("Acuity"), a market-leading indu...
Acuity Inc. Declares Quarterly Dividend
Acuity Inc. Declares Quarterly Dividend Atlanta, June 25, 2025 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE: AYI) will pay a quarterly dividend of 17 cents per share. The dividend is payable on August 1, 2025, to shareholders of record on July 18, 2025. About Acuity Acuity Inc. (NYSE: AYI) is a market-leading industrial technology company. We use technology to solve problems in spaces, light and more things to come. Through our two business segments, Acuity Brands Lighting (ABL) and Acuity Intelligent Spaces (AIS), we design, manufacture, and bring to market products and services that make ...
OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obe...
OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be participating in a fireside discussion moderated by Edward Tentoff, Managing Director, Senior Biotechnology Analyst. Investors can register for the symposium by contacting their Piper Sandler representative. About OPKO Health OPKO is a multinational biopharmaceutical and diagnostics ...
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Gluc...
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that new pharmacologic and pharmacokinetic in vivo data for investigational oral OPK-88006 tablet treatment has been selected for presentation at the ENDO 2025 annual meeting of the Endocrine Society, taking place July 12-15, 2025 in San Francisc...
- Jonathan Moreland
KMPR KEMPER CORPORATION
IPAR INTER PARFUMS INC.
GLP GLOBAL PARTNERS LP
VSH VISHAY INTERTECHNOLOGY INC.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
BMBL BUMBLE
AIRS AIRSCULPT TECHNOLOGIES INC
TYRA TYRA BIOSCIENCES INC
ERNA ETERNA THERAPEUTICS INC.
SDHC SMITH DOUGLAS HOMES CORP
OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Adv...
OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development Will provide expertise across ModeX’s portfolio of next generation multispecific antibodies for complex diseases involving the immune system, including cancer ModeX’s promising immunology pipeline includes first-in class drugs with two assets in ongoing clinical trials and multiple pre-IND assets to enter clinical trials WESTON, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), to...
Acuity to Announce Fiscal 2025 Third-Quarter Results on June 26, 2025
Acuity to Announce Fiscal 2025 Third-Quarter Results on June 26, 2025 ATLANTA, May 29, 2025 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE: AYI) (the “Company”) will release fiscal 2025 third quarter results on Thursday, June 26, 2025 at 6:00 a.m. ET, followed by a conference call at 8:00 a.m. ET. Neil Ashe, Chief Executive Officer of Acuity Inc., will lead the call. The webcast, earnings release, and supplemental presentation can be accessed via the Investor Relations section of the Company's at on Thursday, June 26, 2025. The online replay will remain available for a limited time following ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.